Session 4: Debate and Roundtable - How Do We Define Success in CLL?

Co-Chair(s)

• 

  John Seymour, MBBS, FRACP, PhD

  Director of Department of Haematology
  Royal Melbourne Hospital, Peter MacCallum Cancer Centre and University of Melbourne
  Melbourne, Victoria, Australia
• 

  Lydia Scarfò, MD

  Assistant Professor
  Vita-Salute San Raffaele University
  Milano, Italy

Presentations:

• 3:50 PM – 4:00 PM EDT

  Does the Life Expectancy of Elderly CLL patients receiving upfront Targeted Agents approach the Life Expectancy of the General Population?
  

  Primary Author; Presenting Author: Stefano Molica, MD – Department Hematology, Hull University Teaching Hospitals NHS Trust, Hull, UK

  Co-Author: Tait Shanafelt, MD – Division of Hematology, Department of Medicine, Stanford University School of Medicine, Stanford

  Co-Author: David Allsup, MD – Department Hematology, Hull University Teaching Hospitals NHS Trust

  Co-Author: Diana Giannarelli, PhD – Fondazione Policlinico Universitario Agostino Gemelli IRCCS
• 4:00 PM – 4:35 PM EDT

  Multiparty "Statement of Perspective"
  

  Speaker: William G. Wierda, MD, PhD – University of Texas MD Anderson Cancer Center

  Speaker: Barbara Eichhorst, MD – University Hospital of Cologne

  Speaker: Carsten Utoft Niemann, MD, PhD – Department of Hematology, Copenhagen University Hospital Rigshospitalet, Denmark; Hematology Research Group, Danish Cancer Institute Research Center, Denmark; Department of Clinical Medicine, Copenhagen University

  Speaker: Michele Nadeem Baker, MS, Patient Leader Certificate, Crisis Leadership Certificate – Kicking Cancer In Heels

  Speaker: Danielle M. Brander, MD – Duke University Medical Center
• 4:35 PM – 5:10 PM EDT

  Panel Discussion With Interactivity and Audience Q&A